P41182 (BCL6_HUMAN) Homo sapiens (Human)

B-cell lymphoma 6 protein UniProtKBInterProSTRINGInteractive Modelling

706 aa; Sequence (Fasta) ; (Isoform 2)

Available Structures

108 Experimental Structures

DescriptionPDB IDOligo-stateRangeLigands
Crystal structure of the BCL6 BTB domain complexed with a SMRT co-repressor peptide Heteromer
Q9Y618;
5-129
Assess
Crystal structure of the BCL6 BTB domain dimer in complex with the BCOR BBD corepressor peptide Heteromer
Q6W2J9;
5-129
Assess
Crystal structure of an NCoR1BBD2-BCL6BTB chimera in complex with the NcoR1 BBD1 corepressor peptide Heteromer
O75376;
6-129
28×SO4;GOL;
Assess
Crystal structure of the BCL6 BTB domain in complex with the NCoR1 BBD2 peptide Heteromer
O75376;
6-128
14×NA;CL;TFA;
Assess
Crystal structure of an NCoR1BBD2-BCL6BTB chimera in complex with nebulinSH3-NCoR1BBD1 Heteromer
O75376; P20929;
6-128
NA;
Assess
Crystal structure of the BCL6 BTB domain in complex with a hybrid BTB-binding (HBP) peptide Heteromer
6-128
NA;
Assess
Crystal structure of the talin-KANK1 complex Heteromer
O75376; P26039; Q14678;
6-128
12×SO4;GOL;
Assess
Crystal structure of an NCoR1BBD2-BCL6BTB chimera in complex with the NcoR1 BBD1 corepressor peptid… Heteromer
O75376;
6-127
Assess
Crystal structure of the BCL6 BTB domain in complex with the NCoR1 BBD corepressor peptide Heteromer
O75376;
6-125
NA;EDO;
Assess
Cryo-EM structure of BCL6 bound to BI-3802homo-8-mer7-128
U52;
Assess
Crystal structure of the BCL6 BTB domain in complex with OICR-4425homo-2-mer1-128
YJV;DMS;
Assess
Crystal structure of the BCL6 BTB domain in complex with OICR-7629homo-2-mer2-128
YND;FMT;ACT;CL;
Assess
Crystal structure of human BCL6 BTB domain in complex with compound 13ehomo-2-mer5-129
VJ5; 12×EDO;CL;DMS;
Assess
Crystal structure of human BCL6 BTB domain in complex with compound 8ehomo-2-mer5-129
VHB; 10×EDO;CL;
Assess
Crystal structure of human BCL6 BTB domain in complex with compound 19homo-2-mer5-129
KA0;EDO;CL;DMS;
Assess
Crystal structure of human BCL6 BTB domain in complex with compound 2homo-2-mer5-129
KCB; 10×EDO;
Assess
Crystal structure of human BCL6 BTB domain in complex with compound 22homo-2-mer5-129
K6I;EDO;DMS;
Assess
Crystal structure of human BCL6 BTB domain in complex with compound 12c and its enantiomer 12bhomo-2-mer5-129
VHN;VHZ; 12×EDO;CL;
Assess
Crystal structure of human BCL6 BTB domain in complex with compound 23dhomo-2-mer5-129
NQT; 24×EDO;DMS;
Assess
Crystal structure of human BCL6 BTB domain in complex with compound 4homo-2-mer5-129
97S; 10×EDO;CL;
Assess
Crystal structure of human BCL6 BTB domain in complex with compound 7homo-2-mer5-129
9FW; 10×EDO;DMS;CL;
Assess
Crystal structure of human BCL6 BTB domain in complex with compound 13ghomo-2-mer5-129
VJ2; 12×EDO;DMS;CL;
Assess
Crystal structure of human BCL6 BTB domain in complex with compound 2homo-2-mer5-129
VHQ; 14×EDO;CL;DMS;
Assess
Crystal structure of the BCL6 BTB domain in complex with OICR-12387homo-2-mer5-129
SO4;GOL;CL;E3I;
Assess
Crystal structure of human BCL6 BTB domain in complex with compound 13homo-2-mer5-129
K5I;EDO;DMS;CL;
Assess
Crystal structure of human BCL6 BTB domain in complex with compound 11ahomo-2-mer5-129
NR8;EDO;
Assess
Crystal structure of human BCL6 BTB domain in complex with compound 15homo-2-mer5-129
K8R; 14×EDO;CL;DMS;
Assess
Crystal structure of human BCL6 BTB domain in complex with compound 11fhomo-2-mer5-129
NQN; 10×EDO;DMS;
Assess
Crystal structure of human BCL6 BTB domain in complex with compound 8chomo-2-mer5-129
VH5; 12×EDO;DMS;CL;
Assess
Crystal structure of human BCL6 BTB domain in complex with compound 12bhomo-2-mer5-129
VHZ;EDO;DMS;
Assess
Crystal structure of human BCL6 BTB domain in complex with compound 25ahomo-2-mer5-129
NQW; 16×EDO;DMS;
Assess
Crystal structure of human BCL6 BTB domain in complex with compound 10homo-2-mer5-129
K4O; 18×EDO;DMS;
Assess
Crystal structure of human BCL6 BTB domain in complex with compound 21homo-2-mer5-129
K6R;EDO;CL;
Assess
Crystal structure of human BCL6 BTB domain in complex with compound 18homo-2-mer5-129
K69;EDO;
Assess
Crystal structure of human BCL6 BTB domain in complex with compound 1homo-2-mer5-129
9IH;CL;
Assess
Crystal structure of human BCL6 BTB domain in complex with compound 9ahomo-2-mer5-129
9IE;
Assess
Crystal structure of human BCL6 BTB domain in complex with compound CCT374705homo-2-mer5-129
TWI;EDO;CL;
Assess
Crystal structure of human BCL6 BTB domain in complex with compound 12ahomo-2-mer5-129
9GR;EDO;DMS;
Assess
Crystal structure of human BCL6 BTB domain in complex with compound 7homo-2-mer5-129
K4C;EDO;
Assess
Crystal structure of human BCL6 BTB domain in complex with compound 17ahomo-2-mer5-129
NQQ;EDO;
Assess
Crystal structure of human BCL6 BTB domain in complex with compound 1homo-2-mer5-129
NQZ;EDO;
Assess
Crystal structure of human BCL6 BTB domain in complex with compound 14homo-2-mer5-129
K5U;CL;EDO;DMS;
Assess
Crystal structure of human BCL6 BTB domain in complex with compound 25homo-2-mer5-129
VGW;EDO;DMS;
Assess
Crystal structure of the BCL6 BTB domain in complex with F1324(10-13)homo-2-mer5-129
EDO;
Assess
Crystal structure of human BCL6 BTB domain in complex with compound 12ahomo-2-mer5-129
EBL;CL;EDO;DMS;
Assess
Crystal structure of human BCL6 BTB domain in complex with compound 25bhomo-2-mer5-129
NR5;EDO;
Assess
Crystal structure of the BCL6 BTB domain in complex with OICR-10256homo-2-mer6-129
SO4;GOL;CL;YJJ;
Assess
Crystal structure of human BCL6 BTB domain in complex with compound 11homo-2-mer6-129
K4X; 16×EDO;
Assess
Crystal structure of human BCL6 BTB domain in complex with compound 8fhomo-2-mer6-129
VHK; 12×EDO;CL;
Assess
Crystal structure of human BCL6 BTB domain in complex with compound 17homo-2-mer6-129
KA9; 18×EDO;GOL;DMS;
Assess
Crystal structure of human BCL6 BTB domain in complex with compound 6homo-2-mer6-129
NQK;EDO;
Assess
Crystal structure of human BCL6 BTB domain in complex with compound 4homo-2-mer6-129
NQE;EDO;
Assess
Crystal structure of human BCL6 BTB domain in complex with compound 5homo-2-mer6-129
NQH;DMS;CL;
Assess
HUMAN BCL6 BTB-DOMAIN IN COMPLEX WITH GSK137homo-2-mer5-128
TEQ;GOL;DMS;
Assess
Crystal structure of human BCL6 BTB domain in complex with a WVIP peptidehomo-2-mer6-129
EDO;DMS;
Assess
Crystal structure of the BCL6 BTB domain in complex with OICR-8826homo-2-mer6-128
7RH;SO4;DMS;
Assess
Crystal structure of the BCL6 BTB domain in complex with pyrazolo-pyrimidine ligandhomo-2-mer6-128
8GN;
Assess
Crystal structure of the BCL6 BTB domain in complex with OICR-9322homo-2-mer7-129
7SH;GOL;CA;
Assess
Crystal structure of the BCL6 BTB domain in complex with an Apt48 peptidehomo-2-mer7-129
CL;MG;GOL;NA;
Assess
Crystal structure of the BCL6 BTB domain in complex with OICR-9288homo-2-mer7-129
7SC;DMS;GOL;
Assess
BCL6 BTB domain in complex with 15ahomo-2-mer6-128
F8J;
Assess
Crystal structure of the BCL6 BTB domain in complex with pyrazolo-pyrimidine macrocyclic ligandhomo-2-mer6-128
CL;8GQ;
Assess
Crystal structure of the BCL6 BTB domain in complex with anilinopyrimidine ligandhomo-2-mer6-128
CL;C0Q;
Assess
Crystal structure of the BCL6 BTB domain in complex with OICR-10562homo-2-mer6-128
DMS;E1I;
Assess
Crystal structure of human BCL6 BTB domain in complex with compound 12ehomo-2-mer7-129
VH8;EDO;CL;
Assess
Crystal Structure of the Wild-Type Human BCL6 BTB/POZ Domainhomo-2-mer7-129
Assess
Crystal structure of BCL6 BTB domain in complex with compound 7CC5homo-2-mer7-129
EHY;
Assess
Crystal structure of the BCL6 BTB domain in complex with OICR-9320homo-2-mer7-128
YNA;GOL;
Assess
Crystal structure of the BCL6 BTB domain in complex with OICR-9153homo-2-mer7-128
7SO;DMS;SO4;CL;
Assess
Crystal structure of the BCL6 BTB domain in complex with OICR-10268homo-2-mer7-128
7ST;DMS;
Assess
Crystal structure of the BCL6 BTB domain in complex with OICR-8388homo-2-mer7-128
7S0;FMT;
Assess
Crystal structure of the BCL6 BTB domain in complex with OICR-8828homo-2-mer7-128
828;DMS;SO4;CL;
Assess
Crystal structure of the BCL6 BTB domain in complex with OICR-7859homo-2-mer7-128
7RR;FMT;CL;
Assess
Crystal structure of the BCL6 BTB domain in complex with OICR-8311homo-2-mer7-128
7RW;FMT;
Assess
Crystal Structure of the B-Cell Lymphoma 6 (BCL6) BTB Domain to 1.3 Angstromhomo-2-mer7-128
Assess
Crystal structure of the BCL6 BTB domain in complex with OICR-12694homo-2-mer7-128
YN7;GOL;UNX;
Assess
Crystal structure of the BCL6 BTB domain in complex with OICR-9124homo-2-mer7-128
7R5;SO4;CL;
Assess
Crystal structure of the BCL6 BTB domain in complex with OICR-8446homo-2-mer7-128
7RL;FMT;CL;
Assess
Crystal structure of the BCL6 BTB domain in complex with OICR-11029homo-2-mer7-128
YJS;DMS;SO4;
Assess
Crystal structure of the BCL6 BTB domain in complex with OICR-10269homo-2-mer7-128
7SZ;DMS;
Assess
Crystal structure of an NCoR1BBD2-BCL6BTB chimerahomo-2-mer6-127
MPD;CL;
Assess
Crystal structure of the BCL6 BTB domain in complex with anilinopyrimidine ligandhomo-2-mer7-128
CL;C1W;
Assess
Crystal structure of the BCL6 BTB domain in complex with OICR-8445homo-2-mer7-128
7S5;FMT;CL;
Assess
Crystal structure of the BCL6 BTB-domain with compound 1homo-2-mer6-127
RC0;
Assess
Crystal structure of the BCL6 BTB domain in complex with F1324homo-2-mer7-128
SO4;
Assess
Crystal structure of the BCL6 BTB-domain with compound 2homo-2-mer7-128
TJ3;
Assess
Crystal structure of the BCL6 BTB domain in complex with OICR-11864homo-2-mer7-128
E2E;GOL;CL;
Assess
Crystal Structure of the B-Cell Lymphoma 6 (BCL6) BTB domain to 2.2 Angstromhomo-2-mer7-128
Assess
Crystal structure of the BCL6 BTB domain in complex with OICR-9287homo-2-mer7-128
7RB;
Assess
Crystal Structure of the BCL6 BTB domain complexed with the small molecule inhibitor 79-6homo-2-mer7-128
Z88;Z89;
Assess
CRYSTAL STRUCTURE OF BCL-6 BTB-domain with BI-3802homo-2-mer7-128
U52;
Assess
The structure of BCL6 BTB (POZ) domain in complex with the ansamycin antibiotic rifabutin.homo-2-mer9-128
RBT;
Assess
Crystal structure of the BCL6 BTB domain in complex with Compound 1amonomer5-129
80R;EDO;K;
Assess
Crystal structure of the BCL6 BTB domain in complex with Compound 1monomer5-129
7ZF;
Assess
Crystal structure of the BCL6 BTB domain in complex with Compound 5monomer5-129
80L;
Assess
Crystal structure of the BCL6 BTB domain in complex with Compound 4monomer5-129
7ZL;EDO;
Assess
Crystal structure of the BCL6 BTB domain in complex with Compound 7monomer5-129
7Z6;EDO;K;
Assess
Crystal structure of the BCL6 BTB domain in complex with Compound 5monomer5-129
YAM;
Assess
Crystal structure of the BCL6 BTB domain in complex with Compound 6monomer5-129
7ZO;
Assess
Crystal structure of BCL6 BTB domain with compound 15fmonomer5-128
EGP;
Assess
Crystal structure of the BCL6 BTB domain in complex with anilinopyrimidine ligandmonomer6-128
C0H;
Assess
Crystal structure of a complex of the Miz1- and BCL6 POZ domains.monomer5-127
Assess
Crystal structure of the BCL6 BTB domain in complex with pyrazolo-pyrimidine ligandmonomer7-128
CL;8HN;
Assess
Crystal structure of the BCL6 BTB domain in complex with pyrazolo-pyrimidine ligandmonomer9-128
Assess
Chemical shift assignment of Hr4436B from Homo Sapiens, Northeast Structural Genomics Consortiummonomer540-602
ZN;
Assess
Solution structure of the 1st zf-C2H2 domain from Human B-cell lymphoma 6 proteinmonomer515-544
ZN;
Assess
Solution structure of the C2H2 type zinc finger (region 598-626) of human B-cell lymphoma 6 proteinmonomer598-626
ZN;
Assess
Solution structure of the C2H2 type zinc finger (region 626-654) of human B-cell lymphoma 6 proteinmonomer626-654
ZN;
Assess

3 SWISS-MODEL models

TemplateOligo-stateQMEANDisCoRangeLigandsTrg-Tpl Seq id (%)
6xmx.1.Amonomer0.757-128
99.72
Assess
5v3j.2.Cmonomer0.53472-684
ZN;32.39
Assess
5v3j.2.Cmonomer0.53470-682
ZN;MG;34.11
Assess

3 SWISS-MODEL models built on isoform sequence

TemplateIsoformOligo-stateQMEANDisCoRangeLigandsTrg-Tpl Seq id (%)
Isoform 26xmx.1.Amonomer0.777-128
99.72
Assess
Isoform 25v3g.1.Cmonomer0.53470-625
ZN;45.39
Assess
Isoform 25wjq.1.Cmonomer0.50470-627
ZN;33.54
Assess